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ABSTRACT 
 
Asthma is a chronic obstructive pulmonary disease (COPD) which affects 1 in every 12 
Americans. Symptoms common to asthmatics include dyspnea, increased mucous 
production and airway hyperresponsiveness. While research over the past few decades 
has mostly established the immunological basis behind asthma, there have not been 
radical changes in the treatment modalities. It is believed that in many COPDs, alveolar 
macrophages play a critical role in disease progression. While evolutionarily, alveolar 
macrophages played a significant part in protecting the individual from harmful allergens, 
in asthma there may be an inappropriate activation of the alveolar macrophages to 
proteases such as cockroach allergen (CRA). Studies show that children living in inner 
cities with cockroach infestation are more likely to develop asthma than those that reside 
in rural areas with less exposure to cockroach allergens. In exposed individuals, when the 
alveolar macrophages come in contact with CRA, an immune cascade is initiated which 
sensitizes the child. Subsequent exposure to such an antigen will induce asthma like 
symptoms. One possible way of reducing such a response is to reduce the number of 
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alveolar macrophages thus avoiding the pathalogical effects. Clodronate liposomes are 
liposomes that are encapsulated with bisphosphonate clodronate. When a macrophage 
phagocytoses such a liposome, the result is cellular suicide or apoptosis. In this study, we 
sensitized a murine model of CRA asthma and then monitored the impact of depleted 
alveolar macrophages using intratracheal administration of clodronate liposomes. We 
then studied the effect of this depletion on the recruitment of inflammatory cells such as 
neutrophils and eosinophils which are primary cellular contributors to the asthmatic 
response. Our studies show that while clodronate liposomes are effective in alveolar 
macrophage depletion, the subsequent inflammation through neutrophil recruitment 
interferes with the study of the delicate milieu of cells in the respiratory epithelium of this 
murine model. 
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INTRODUCTION 
 
Asthma is a chronic obstructive lung disease that currently affects 300 million 
people worldwide (Kudo, Ishigatsubo & Aoki, 2013). According to  American Academy 
of Allergy Asthma and Immunology (AAAAI), in the United States alone, 1 in every 12 
individuals are suffering from asthma which accounts for about 8% of the U.S. 
population (AAAAI, 2010). If the serious health problems caused by asthma are put aside 
for a moment, there is also an immense socioeconomic burden that accompanies the 
disease. In the United States, the costs in treating asthmatic patients has gone up from 
$53 billion in 2002 to about $56 billion in 2007 which accounts to a 6% rise in costs 
(AAAAI, 2010).  
Over the past few decades, the advancement in technology and laboratory 
techniques has allowed scientists to better understand the pathophysiology of asthma. But 
the treatment modalities used to relieve the symptoms have not experienced the same 
level of radical advancement. The conventional treatment for asthma still involves the 
usage of beta-agonists in the case of mild asthma and inhaled steroid therapy in persistent 
or severe asthma (Busse et al, 2008). While these pharmacologic interventions are 
effective in relieving asthmatic symptoms and preventing a crisis, they are not a long 
term cure for this progressive disease. Future therapeutic advancements for the treatment 
of asthma requires a deeper understanding of the pathogenesis of the disease, so the 
emerging treatments can focus on affecting the etiology of the disease than trying to stop 
its progression. 
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Asthma is a subclass of COPD which involves reversible airway obstruction due 
to bronchiolar constriction (figure 1). Asthmatics experience increased: smooth muscle 
contraction, mucous production, airway inflammation and airways hyperresponsiveness 
which prevent them from performing a normal exhalation. Additional symptoms include 
wheezing, chest tightness and difficulty breathing. While there is a genetic predisposition 
in asthmatics, 90% of asthma cases have an identifiable environmental agent (CDC, 
2012). According to Dr. Daniel Remick, approximately 50% of asthma patients in the 
inner city areas are allergic to cockroach allergen (Elissa, 2009). Since asthma is a 
common illness among children and individuals living in urban areas with low socio-
economic index, cockroach infestation has shown to be a significant causative agent for 
asthma. The contents of cockroach allergen which are thought to activate the innate and 
adaptive branches of immune system are shown in Table 1. Among these substances, 
Blag1 and Blag2 are most significant and are found mostly in voids of German cockroach 
body parts as well as in fecal droppings Field et al, 2013). Blag1 has been shown to cause 
asthma symptoms in sensitive individuals at concentrations as low as 8U/g. (EMSL 
Analytical, 2013). 
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Figure 1. Bronchiolar obstruction as seen in an acute asthmatic response. Secondary 
exposure of sensitized allergen to the respiratory mast cells results in the release of 
histamine granules which eventually cause smooth muscle constriction in the terminal 
and respiratory bronchioles of an asthmatic. (Adapted from Bronchial Asthma-Emerging 
Therapeutic Strategies, Elizabeth Sapey, 2012) 
 
 
Component  Biological Action Innate/ Adaptive 
Blag1/ Blag2 
 
Protein antigen Adaptive 
 
LPS 
 
TLR4/CD14/MD2 Ligand Innate 
 
Chitin  
Macrophage mannose receptor,  
TLR2, leukotriene B4 receptor ligand 
Innate 
Other  Proteases Both 
 
Table 1. Biological composition of cockroach allergen as obtained from Blatella 
germanica. Considering the myraid of substances present in CRA which could possibly 
induce an acute immune response in asthmatics, Blag1 and Blag2 are the most potent.   
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While there is locus heterogeneity in the extent and severity of asthma in 
genetically susceptible individuals, it has been established that the sensitization and 
progression of the disease follows a similar pattern of immunopathogenesis (figure 2). 
When a predisposed individual inhales a novel allergen such as cockroach allergen, the 
dendritic cells and macrophages present in the lumen of the respiratory tract interact with 
the allergen. These antigen presenting cells with the antigen-receptor complex can then 
travel to the local lymph nodes where they present the antigen to a CD4+ T lymphocyte. 
If the T lymphocyte recognizes the antigen as a foreign particle which could compromise 
the immune integrity, it undergoes clonal expansion and production of Th2 type 
cytokines IL-4, IL-5, IL-6, IL-9 and IL-13. Cytokines IL-4 and IL-13 activate the 
immature B cells in the lymph nodes to clonally expand and produce IgE antibodies 
specific to the inhaled allergen. The resulting IgE antibodies travel back to the respiratory 
lumen and bind to the receptors on the membrane of mast cells. Secondary exposure to 
the sensitizing antigen results in binding of the offending agent to IgE antibodies, 
subsequent crosslinking of IgE receptors followed by mast cell degranulation releasing 
histamine. Histamine causes an increase in vascular permeability at the post-capillary 
venules resulting in extravasation of leukocytes and proteins to engage the offending 
pathogen. IL-5 is another important Th2 cytokine required for eosinophillic proliferation. 
Eosinophils are key cells in propagating the asthmatic response. They produce monocyte 
chemotactic factors such as eotaxin-1 (CCL11) and eotaxin-2 (CCL24) which could then 
indirectly cause a rise in the alveolar macrophage population. Eosinophils also play a 
major role in causing airway hyperresponsiveness and mucous production during an 
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asthmatic response (Kay, 2005). The charcot-laden crystals commonly seen in the sputum 
of asthmatics consists of the eosinophil basic protein produced by eosinophils. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Sensitization to inhaled allergen in asthmatics. Exposure of an inhaled 
antigen to the innate immune cells of the respiratory tract result in clonal expansion of 
antigen specific B cells and production of IgE antibodies which bind to mast cells and 
equip the individual to future exposure to the sensitized allergen. (Adapted from Models 
of Exacerbations in Asthma and COPD, A.Schmidt and H.Herwald, 2007) 
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Based on the amount of allergen exposure, the sensitized individual can 
experience acute symptoms followed by a late-phase (figure 3). The early-phase of 
asthmatic response involves cross-linking of IgE receptors on mast cells resulting in mast 
cell degranulation and histamine release resulting in acute bronchoconstriction. This early 
phase of response could then be followed by a late-phase where-in the resident 
macrophages and dendritic cells can then recruit pro-inflammatory mediators and cells 
such as eosinophils and neutrophils to the affected area. 
 
Figure 3. Phases of asthmatic response. Exposure to sensitized allergen in low 
concentrations induces the early-phase response which consists of mast cell degranulation 
and resulting bronchoconstriction. Chronic exposure to high concentrations of the 
allergen initiates a late-phase response where the resident dendritic cells and 
macrophages present the antigen to CD4+ T helper cells which recruit eosinophils 
resulting in prolonged inflammation. (Adapted from Models of Exacerbations in Asthma 
and COPD, A.Schmidt, H.Herwald, 2007) 
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In most cases of COPDs such as asthma, emphysema and chronic bronchitis, there 
is increasing evidence that the alveolar macrophages are the driving cells in inflammation 
through the release of inflammatory cytokines which attract monocytes, neutrophils and 
T cells to the affected area (figure 4). Evolutionarily, the alveolar macrophages do have a 
protective role against agents invading the respiratory epithelium, in asthma there is an 
inappropriate activation of these alveolar macrophages against antigens like the 
cockroach allergen. This unwarranted activation of the immune system is no longer 
protective in nature but is harmful for the survival of the affected individual. Given this 
critical role of macrophages in immune related diseases, if the macrophage population 
involved in immune related diseases is effectively reduced, it is possible to limit the 
pathology. One such compound used to induce various tissue macrophages to commit 
suicide is bisphosphonate clodronate. Studies have shown that liposomes encapsulating 
bisphosphonate clodronate are capable of causing apoptosis of tissue specific 
macrophages such as Kupfer cells in the liver, splenic macrophages in the spleen and 
alveolar macrophages in the lungs (Rooijen & van Kesteren-Hendrikx, 2003). 
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Figure 4. Immunological role of macrophages in inducing an asthmatic response. 
This figure shows an overview of the critical role that macrophages play in asthma. 
Through the release of cytokines and chemokines, macrophages activate a myriad of 
potent immune cells which propagate the asthmatic response. The resulting phenotype of 
such an activation includes bronchoconstriction, airway fibrosis, inflammation and mucus 
hypersecretion. (Adapted from Pappas et al, 2013) 
 
OBJECTIVES 
 
Considering the critical role that alveolar macrophages play in the propagation 
and progression of asthma symptoms, being able to study the immunological response in 
the absence of alveolar macrophages will contribute to our understanding of the pathways 
involved. With the advent of clodronate liposomes (Rooijen, 1989) it is now possible to 
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understand the role of alveolar macrophages in the recruitment of inflammatory 
mediators and other role players in the asthmatic response. Following the depletion of 
alveolar macrophages using clodronate liposomes, we can monitor the bronchoalveolar 
milieu for changing cell types and numbers (figure 5). Considering the role of 
macrophages in the recruitment of eosinophils and neutrophils, we expect that depleting 
the alveolar macrophages should reduce the BAL levels of these two cell types. Which 
should in turn should reduce inflammatory responses and mucous production. While the 
affect that the dying macrophages will have on the surrounding alveolar environment is 
still unknown, we expect an overall decrease in asthmatic response using clodronate 
liposomes compared to control. 
 
Figure 5: Macrophage depletion experiment using clodronate liposomes. Clodronate 
liposomes are effective in inducing macrophage apoptosis. The above flow cytometry 
results show that compared to control, clodronate liposomes deplete 90% of macrophage 
pool in a mouse spleen 24 hrs following an intraperitoneal injection. (Adapted from 
FormuMax Scientific Inc, 2013) 
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METHODS 
Experimental model: 
For this experiment, female HSD-ICR mice were used (Harlan Sprague Dawley 
Inc.,) By using outbred mice, we tried to replicate the genetic variability seen in 
individuals susceptible to asthma. The stock clodronate and empty liposomes were 
obtained from Dr. Nico Van Rooijen (1007 MB, Amsterdam, Netherlands). The data 
obtained represents the combination of 2 replicates for all conditions. All experiments 
were approved by the Institutional Animal Care and Use Committee at Boston University 
School of Medicine.  
Allergen sensitization: 
CRA extract from German cockroach Blatella germanica was purchased from 
Greer Laboratories (Lenoir, NC, Item# 46). The CRA was then reconstituted in sterile 
PBS so that 50 ul of PBS solution containing 8 ug of combined Blag1 and Blag2.  
To start the procedure, the mice are first anesthetized using 250 ul of isofluorine until the 
pulse drops to around 60 bpm. Then 2x 20 ul (total 40 ul) of freshly made CRA is then 
instilled intratracheally (figure 6). A successful instillation is consistent with observing 
foamy bubbles coming out of the nasal passages. The anesthetized mouse is then allowed 
to recover in an incubator at 37oC and then returned to its cage. Identical steps are taken 
with the control mice, except that CRA is replaced with the same quantity of PBS. 
Figures 7 and 8 show variations in experimental timeline in order to determine the effect 
of acute macrophage depletion on asthmatic response (figure 7) compared to prolonged 
macrophage depletion (figure 8) 
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Figure 6: Intratracheal instillation of CRA and PBS. Anesthetized mouse is 
suspended by their dentition and 2 doses of 20 ul of CRA or PBS is then pipetted into the 
trachea. A proper installation can be confirmed visually by the foamy bubbles near the 
nostrils.  
 
 
Experimental timeline: 
Timeline 1: 
 
Figure 7: Acute macrophage depletion following sensitization. From the timeline 
above, we can see that the first day when the mice are exposed to either CRA or PBS is 
denoted as day 0. On day 14, the mice receive a second dose of either CRA or PBS. On 
days 17, 18 and 19, the mice receive 2x 20 ul of either clodronate liposomes or empty 
liposomes by the same technique as seen in figure 6. On day 21, the mice receive their 3rd 
and final CRA dose and are sacrificed using approved protocols on day 22. 
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Timeline 2: 
 
 
Figure 8: Prolonged macrophage depletion prior to and following CRA 
sensitization. 3 days prior to the mice receiving their first dose of either CRA or PBS, the 
mice are exposed to either clodronate liposomes or control in order to deplete 
macrophages prior to sensitization. The mice are then exposed to CRA or PBS on days 0, 
11 and 21. In between CRA treatments, the mice receive either clodronate liposomes or 
empty liposomes on days 1, 4, 7, 14 and 18. The mice are then sacrificed on day 22 using 
approved protocols.  
 
 
Sacrifice and data collection: 
On day 22, the mice are sacrificed by exposure to isofluorine followed by cervical 
dislocation. In order to obtain the immune cells, bronchoalveolar lavage (BAL) was 
performed using 5 ml of HBSS. The first ml of solution obtained through the BAL is 
used for cytokine detection whereas the next 18 ml are used to perform a differential 
BAL cell count. The left lung is then removed and placed in 70% ethanol for histology. 
The BAL cells are then centrifuged and stained with trypan blue in order to count the 
number of viable macrophages. 
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RESULTS 
Macrophage depletion in naïve mice: 
This initial experiment was performed to determine the effect of clodronate 
liposomes on macrophage depletion and differential count (figure 9). In this experiment, 
the liposomes were instilled intratracheally on day 0 and mice were then sacrificed at 
various time periods to determine the effectiveness of clodronate liposomes over a 
prolonged period. We can see from figure 9 that over a period of 72 hours after 
instillation of clodronate liposomes, the macrophage count decreased from an initial 
count of 9.0x105 to 5.0x105. Meanwhile, the neutrophils which are not present in a naïve 
mice increase in number to 4.2x105 about 48 hours post clodronate liposome instillation. 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Differential BAL count following clodronate liposomes in naïve mice. 72 
hours post clodronate liposome treatment, there is significant decrease in BAL 
macrophage count whereas a significant increase in BAL neutrophil count post 48 hours. 
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Acute macrophage depletion: 
 
As indicated in figure 7, following 2 doses of CRA challenge, on days 17, 18 and 
19, the mice were exposed to either clodronate or empty PBS liposomes. Following 
timeline 1 on day 22, the total BAL cell count shows a significant increase in the mice 
which received CRA and clodronate liposomes (8x108) compared to mice which received 
CRA and empty liposomes (5.8x108). 
 
                 (x 108)                               
                      * 
 
 
 
 
 
 
 
Figure 10: Total BAL cell count, post-acute macrophage depletion. The total number 
of BAL cells is significantly greater in mice group which received CRA and clodronate 
liposomes compared to those which received CRA with control (p < 0.05) 
 
The cells obtained in the BAL were then stained and differentially counted. The 
results as seen in figure 11 show that the group which received CRA and clodronate had a 
significantly greater number of macrophages compared to the group which received CRA 
and empty liposomes. 
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          * 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: BAL differential count (in millions), post-acute macrophage depletion. 
The group which received acute doses on clodronate liposomes on days 17, 18 and 19 
had significantly greater number of macrophages in the BAL compared to the control 
group which received CRA and empty liposomes (p < 0.05) 
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Prolonged macrophage depletion experiment: 
Following timeline 2 the mice received intermittent doses of either clodronate or 
empty liposomes approximately every 3 days. The BAL counts show that there is no 
significant different in the total cell count between the groups which received CRA with 
clodronate liposomes and CRA with empty liposomes. 
Total cells
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Figure 12: Total BAL count in mice that receive CRA and either clodronate or 
empty liposomes. No significant difference in BAL cell count is seen in mice groups 
which received empty or clodronate liposomes with CRA (p > 0.05) 
 
 
Figure 13 shows the differential cell count from the BAL. We can see from this 
figure that sensitized mice groups which received intermittent doses of clodronate 
liposomes have a significant decrease in the number of eosinophils. On the other hand, 
consistent with figure 9, there is a significant increase in the total neutrophil infiltrate in 
group which received clodronate liposomes compared to control (p < 0.05) 
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Figure 13: BAL differential count in mice which received CRA with either 
clodronate or empty liposomes. There is a significant decrease in the total number of 
eosinophils in sensitized mice which received clodronate liposomes compared to the 
sensitized control group which received empty liposomes. There is also an increase in the 
total neutrophil count in the clodronate group compared to the empty liposome group. 
 
The neutrophils and eosinophils obtained from the BAL fluid were then analyzed 
with MPO and EPO assay to measure the activity of myeloperoxidase and eosinophil 
peroxidase respectively. The results as seen in figure 14 show that there is a significant 
decrease in the EPO activity in mice which received CRA with clodronate liposomes 
compared to the group that received CRA with empty liposomes. The activity of MPO in 
each of the 2 BAL fluids is similar 
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                                                  *          
 
 
 
 
Figure 14: MPO and EPO assay of BAL cells from timeline 2. A significant difference 
in EPO activity is observed in the experimental group which received clodronate 
liposomes compared to the control group which received empty liposomes (p < 0.05). 
MPO activity between the 2 groups is similar (p > 0.05).  
 
DISCUSSION 
 
In this study, we determined that while it is possible to deplete the alveolar 
macrophages using clodronate liposomes, thus interfering with the macrophage 
recruitment of inflammatory cells, the ensuing cellular milieu hinders the study of CRA 
induced asthmatic model. Some studies show that depletion of alveolar macrophages 
using clodronate liposomes following sensitization in fact increases the recruitment of 
eosinophils and lymphocytes and causes production of Th2 cytokines IL-4, IL-5 and GM-
CSF (Bang et al, 2011). In our initial study of clodronate liposomes (figure 9), we see 
that over 72 hours, although there is a decline in the number of alveolar macrophages, 
there is a reciprocal increase in the number of neutrophils which is consistent with 
published studies. A study by Mircescu et al (2009) shows that in mice treated with 
0.2
0.22
0.24
0.26
0.28
0.3
0.32
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clodronate liposomes, the neutrophil counts in the BAL fluid were marginally higher 
compared to mice that are treated with PBS liposomes or no liposomes. In a sense, the 
dying macrophages are being replaced by neutrophils. Another way to look at this is that 
while clodronate liposomes supposedly causes macrophage death through apoptosis, 
there is some form of an inflammatory response taking place which is resulting in an 
acute neutrophil infiltration. Stains of macrophage depleted BALs show a great extent of 
debris surrounded by neutrophillic infiltrate compared to BALs of mice which received 
PBS liposomes which consist of intact macrophages and limited number of neutrophils 
(images not shown). Figure 11 shows that during an acute clodronate liposome 
administration, there is a significant increase in macrophage recruitment even following 
macrophage depletion. These results contradict previous studies as to the effectiveness of 
clodronate liposomes in macrophage depletion and inhibition of macrophage recruitment. 
In figure 10 we see that following acute clodronate liposome administration, there is an 
increase in the total number of cells compared to mice which received empty liposomes. 
This increase in cell number could be attributed to the above mentioned increase in 
neutrophil and monocyte recruitment. Overall, through experiment 1 (figures 10 and 11), 
we can interpret that although clodronate liposomes might be effective in alveolar 
macrophage depletion in naïve mice, in the CRA sensitized mice, the corresponding 
recruitment of inflammatory cells which include neutrophils but also macrophages 
interferes with the immunological study of CRA induced asthmatic model. In such 
circumstances, it is difficult to establish the contribution of macrophage depletion in 
inhibiting the asthmatic response.  
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In order to study the effect of acute versus prolonged administration of clodronate 
liposomes, experiment 2 was performed (figures 12 and 13). Theoretically, by spacing 
out the administration of clodronate liposomes, we are giving the inflammatory cells such 
as neutrophils time to clean up the debris left from dead macrophages thus preventing 
further recruitment of monocytes. In this modified experiment, we see that frequent but 
intermittent doses of clodronate liposomes throughout the model depletes macrophages 
without causing a massive amount of inflammation. Compared to experiment 1, in 
experiment 2 we can see that there is no significant rise in the total number of cells 
following administration of clodronate liposomes (figure 12). Once again, as in 
experiment 1, there is a significant rise in the total number of neutrophils in the 
clodronate liposome group compared to the control (figure 13). But a difference in this 
model is the total number of eosinophils. Compared to the control group which received 
CRA along with PBS liposomes, the experimental group which received CRA with 
clodronate liposomes had a significant decrease in the total number of eosinophils and 
eotaxin production (figure 13 and 14).  
A recently published study by Beal et al (2013) shows that autologous transfer of 
peritoneal macrophages into the respiratory epithelium of a CRA sensitized mice shows 
reduced recruitment of eosinophils and production of eotaxin. This study brings into 
question the type of macrophage that is being depleted using clodronate liposomes as not 
all macrophages induce inflammatory responses. While the macrophages that are most 
commonly associated with asthmatic response are those that are classically activated 
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(M1), destruction of alternatively activated macrophages (M2) by clodronate liposomes 
can exacerbate the asthmatic response rather than inhibiting it.  
Considering the interrelationship between the various immune cells in asthmatic 
response, in order to study the immunology, it is important to be able to interfere with 
just a single factor in the disease process while holding all others constant. Clodronate 
liposomes while effective in depleting alveolar macrophages in a naïve lung, are also 
capable of interfering with the cellular environment established in an asthmatic lung. We 
recommend that future studies implement a more efficient way of macrophage depletion 
which does not interfere with too many factors in asthmatic response which could 
possibly sidetrack the study. In addition, following such macrophage depletion, it is 
important to measure its effect on other asthmatic parameters such as mucous production, 
airway hyperresponsiveness and cytokine production. Such experiments could possibly 
paint a better picture of the role of alveolar macrophages on asthmatic response. 
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